Therapeutic and diagnostic applications of extracellular vesicles

Journal of Controlled Release

Volumn 244, Issue , 2016, Pages 167-183

  Stremersch, Stephan ^a   De Smedt, Stefaan C ^a   Raemdonck, Koen ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Biomarker; Diagnostics; Drug delivery; Exosomes; Extracellular vesicles; Vaccination

Indexed keywords

CONTROLLED DRUG DELIVERY; DIAGNOSIS; DRUG DELIVERY; PHYSIOLOGY; PLASMA DIAGNOSTICS; TARGETED DRUG DELIVERY; VACCINES;

DIAGNOSTIC APPLICATIONS; DRUG DELIVERY VEHICLES; EXOSOMES; EXTRACELLULAR; INTERCELLULAR COMMUNICATIONS; MOLECULAR COMPOSITIONS; THERAPEUTIC APPLICATION; VACCINATION;

BIOMARKERS;

BIOLOGICAL MARKER; NANOCARRIER;

ARTICLE; BIOLOGICAL ACTIVITY; CELL FREE SYSTEM; CELL FUNCTION; CELL HETEROGENEITY; DRUG DELIVERY SYSTEM; EXOSOME; EXTRACELLULAR MATRIX; HUMAN; INTRACELLULAR MEMBRANE; MOLECULAR STABILITY; NONHUMAN; ORGANELLE BIOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; VACCINATION; ANIMAL;

ANIMALS; BIOMARKERS; DRUG DELIVERY SYSTEMS; EXTRACELLULAR VESICLES; HUMANS;

EID: 84995608724     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.07.054     Document Type: Article

References (259)

1. [1] Wolf, P., The nature and significance of platelet products in human plasma. Br. J. Haematol. 13 (1967), 269–288.
2. [2] Bonucci, E., Fine structure of early cartilage calcification. J. Ultrastruct. Res. 20 (1967), 33–50.
3. [3] Dalton, A.J., Microvesicles and vesicles of multivesicular bodies versus “virus-like” particles. J. Natl. Cancer Inst. 54 (1975), 1137–1148.
4. [4] Dvorak, H.F., Quay, S.C., Orenstein, N.S., Dvorak, A.M., Hahn, P., Bitzer, A.M., Carvalho, A.C., Tumor shedding and coagulation. Science 212 (1981), 923–924.
5. [5] Pan, B.T., Johnstone, R.M., Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33 (1983), 967–978.
6. [6] Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L., Turbide, C., Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262 (1987), 9412–9420.
7. [7] Johnstone, R.M., The Jeanne Manery-Fisher Memorial Lecture, Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem. Cell Biol. 70:1992 (1991), 179–190.
8. [8] Johnstone, R.M., Mathew, A., Mason, A.B., Teng, K., Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J. Cell. Physiol. 147 (1991), 27–36.
9. [9] Raposo, G., Nijman, H.W., Stoorvogel, W., Liejendekker, R., Harding, C.V., Melief, C.J., Geuze, H.J., B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183 (1996), 1161–1172.
10. [10] Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4 (1998), 594–600.
11. [11] Pisitkun, T., Shen, R.F., Knepper, M.A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 13368–13373.
12. [12] Skog, J., Wurdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T. Jr., Carter, B.S., Krichevsky, A.M., Breakefield, X.O., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10 (2008), 1470–1476.
13. [13] Escudier, B., Dorval, T., Chaput, N., Andre, F., Caby, M.P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., Boccaccio, C., Bonnerot, C., Dhellin, O., Movassagh, M., Piperno, S., Robert, C., Serra, V., Valente, N., Le Pecq, J.B., Spatz, A., Lantz, O., Tursz, T., Angevin, E., Zitvogel, L., Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J. Transl. Med., 3, 2005, 10.
14. [14] Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–U672.
15. [15] Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., Ratajczak, M.Z., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20 (2006), 847–856.
16. [16] Cocucci, E., Meldolesi, J., Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 25 (2015), 364–372.
17. [17] Saraste, A., Pulkki, K., Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45 (2000), 528–537.
18. [18] Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M.J., Spetz, A.L., Holmgren, L., Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 6407–6411.
19. [19] Holmgren, L., Szeles, A., Rajnavolgyi, E., Folkman, J., Klein, G., Ernberg, I., Falk, K.I., Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93 (1999), 3956–3963.
20. [20] Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brugger, B., Simons, M., Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319 (2008), 1244–1247.
21. [21] D'Souza-Schorey, C., Clancy, J.W., Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 26 (2012), 1287–1299.
22. [22] Huotari, J., Helenius, A., Endosome maturation. EMBO J. 30 (2011), 3481–3500.
23. [23] Savina, A., Vidal, M., Colombo, M.I., The exosome pathway in K562 cells is regulated by Rab11. J. Cell Sci. 115 (2002), 2505–2515.
24. [24] Lasser, C., O'Neil, S.E., Ekerljung, L., Ekstrom, K., Sjostrand, M., Lotvall, J., RNA-containing exosomes in human nasal secretions. Am. J. Rhinol. Allergy 25 (2011), 89–93.
25. [25] Poliakov, A., Spilman, M., Dokland, T., Amling, C.L., Mobley, J.A., Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 69 (2009), 159–167.
26. [26] Caby, M.P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., Bonnerot, C., Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17 (2005), 879–887.
27. [27] Jahn, R., Scheller, R.H., SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 7 (2006), 631–643.
28. [28] Lotvall, J., Hill, A.F., Hochberg, F., Buzas, E.I., Di Vizio, D., Gardiner, C., Gho, Y.S., Kurochkin, I.V., Mathivanan, S., Quesenberry, P., Sahoo, S., Tahara, H., Wauben, M.H., Witwer, K.W., Thery, C., Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell Vesicles, 3, 2014, 26913.
29. [29] Mathivanan, S., Fahner, C.J., Reid, G.E., Simpson, R.J., ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40 (2012), D1241–D1244.
30. [30] Guescini, M., Genedani, S., Stocchi, V., Agnati, L.F., Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J. Neural Transm. (Vienna, Austria: 1996) 117 (2010), 1–4.
31. [31] Munich, S., Sobo-Vujanovic, A., Buchser, W.J., Beer-Stolz, D., Vujanovic, N.L., Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology 1 (2012), 1074–1083.
32. [32] Andre, F., Schartz, N.E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., Tursz, T., Amigorena, S., Raposo, G., Angevin, E., Zitvogel, L., Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360 (2002), 295–305.
33. [33] Lugini, L., Cecchetti, S., Huber, V., Luciani, F., Macchia, G., Spadaro, F., Paris, L., Abalsamo, L., Colone, M., Molinari, A., Podo, F., Rivoltini, L., Ramoni, C., Fais, S., Immune surveillance properties of human NK cell-derived exosomes. J. Immunol. 189 (2012), 2833–2842.
34. [34] Llorente, A., Skotland, T., Sylvanne, T., Kauhanen, D., Rog, T., Orlowski, A., Vattulainen, I., Ekroos, K., Sandvig, K., Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim. Biophys. Acta 1831 (2013), 1302–1309.
35. [35] Escola, J.M., Kleijmeer, M.J., Stoorvogel, W., Griffith, J.M., Yoshie, O., Geuze, H.J., Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273 (1998), 20121–20127.
36. [36] Nolte-'t Hoen, E.N., Buermans, H.P., Waasdorp, M., Stoorvogel, W., Wauben, M.H., t'Hoen, P.A., Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 40 (2012), 9272–9285.
37. [37] Pigati, L., Yaddanapudi, S.C., Iyengar, R., Kim, D.J., Hearn, S.A., Danforth, D., Hastings, M.L., Duelli, D.M., Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One, 5, 2010, e13515.
38. [38] Villarroya-Beltri, C., Gutierrez-Vazquez, C., Sanchez-Cabo, F., Perez-Hernandez, D., Vazquez, J., Martin-Cofreces, N., Martinez-Herrera, D.J., Pascual-Montano, A., Mittelbrunn, M., Sanchez-Madrid, F., Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun., 4, 2013, 2980.
39. [39] Bolukbasi, M.F., Mizrak, A., Ozdener, G.B., Madlener, S., Strobel, T., Erkan, E.P., Fan, J.B., Breakefield, X.O., Saydam, O., miR-1289 and “zipcode”-like sequence enrich mRNAs in microvesicles, molecular therapy. Nucleic acids, 1, 2012, e10.
40. [40] Guduric-Fuchs, J., O'Connor, A., Camp, B., O'Neill, C.L., Medina, R.J., Simpson, D.A., Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics, 13, 2012, 357.
41. [41] Collino, F., Deregibus, M.C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., Camussi, G., Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One, 5, 2010, e11803.
42. [42] Villarroya-Beltri, C., Baixauli, F., Gutierrez-Vazquez, C., Sanchez-Madrid, F., Mittelbrunn, M., Sorting it out: regulation of exosome loading. Semin. Cancer Biol. 28 (2014), 3–13.
43. [43] Colombo, M., Moita, C., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L.F., Thery, C., Raposo, G., Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell Sci. 126 (2013), 5553–5565.
44. [44] van Niel, G., Charrin, S., Simoes, S., Romao, M., Rochin, L., Saftig, P., Marks, M.S., Rubinstein, E., Raposo, G., The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev. Cell 21 (2011), 708–721.
45. [45] Koppers-Lalic, D., Hackenberg, M., Bijnsdorp, I.V., van Eijndhoven, M.A., Sadek, P., Sie, D., Zini, N., Middeldorp, J.M., Ylstra, B., de Menezes, R.X., Wurdinger, T., Meijer, G.A., Pegtel, D.M., Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 8 (2014), 1649–1658.
46. [46] Tosar, J.P., Gambaro, F., Sanguinetti, J., Bonilla, B., Witwer, K.W., Cayota, A., Assessment of small RNA sorting into different extracellular fractions revealed by high-throughput sequencing of breast cell lines. Nucleic Acids Res. 43 (2015), 5601–5616.
47. [47] Thery, C., Regnault, A., Garin, J., Wolfers, J., Zitvogel, L., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S., Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147 (1999), 599–610.
48. [48] Koliha, N., Wiencek, Y., Heider, U., Jungst, C., Kladt, N., Krauthauser, S., Johnston, I.C., Bosio, A., Schauss, A., Wild, S., A novel multiplex bead-based platform highlights the diversity of extracellular vesicles. J. Extracell Vesicles, 5, 2016, 29975.
49. [49] King, H.W., Michael, M.Z., Gleadle, J.M., Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer, 12, 2012, 421.
50. [50] Kucharzewska, P., Christianson, H.C., Welch, J.E., Svensson, K.J., Fredlund, E., Ringner, M., Morgelin, M., Bourseau-Guilmain, E., Bengzon, J., Belting, M., Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 7312–7317.
51. [51] Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., Colone, M., Tatti, M., Sargiacomo, M., Fais, S., Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284 (2009), 34211–34222.
52. [52] Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X., Sun, Q., Wang, K., Ba, Y., Wang, Q., Wang, D., Yang, J., Liu, P., Xu, T., Yan, Q., Zhang, J., Zen, K., Zhang, C.Y., Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39 (2010), 133–144.
53. [53] Segura, E., Amigorena, S., Thery, C., Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol. Dis. 35 (2005), 89–93.
54. [54] Kim, S.H., Lechman, E.R., Bianco, N., Menon, R., Keravala, A., Nash, J., Mi, Z., Watkins, S.C., Gambotto, A., Robbins, P.D., Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174 (2005), 6440–6448.
55. [55] Li, J., Lee, Y., Johansson, H.J., Mager, I., Vader, P., Nordin, J.Z., Wiklander, O.P., Lehtio, J., Wood, M.J., Andaloussi, S.E., Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles. J. Extracell Vesicles, 4, 2015, 26883.
56. [56] Caracciolo, G., Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. Nanomedicine 11 (2015), 543–557.
57. [57] Betker, J.L., Gomez, J., Anchordoquy, T.J., The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency. J. Control. Release 171 (2013), 261–268.
58. [58] van der Meel, R., Fens, M.H., Vader, P., van Solinge, W.W., Eniola-Adefeso, O., Schiffelers, R.M., Extracellular vesicles as drug delivery systems: lessons from the liposome field. J. Control. Release 195 (2014), 72–85.
59. [59] Bobrie, A., Colombo, M., Krumeich, S., Raposo, G., Thery, C., Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J. Extracell Vesicles, 1, 2012.
60. [60] van Niel, G., Raposo, G., Candalh, C., Boussac, M., Hershberg, R., Cerf-Bensussan, N., Heyman, M., Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121 (2001), 337–349.
61. [61] Willms, E., Johansson, H.J., Mager, I., Lee, Y., Blomberg, K.E., Sadik, M., Alaarg, A., Smith, C.I., Lehtio, J., El Andaloussi, S., Wood, M.J., Vader, P., Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci. Rep., 6, 2016, 22519.
62. [62] Smith, Z.J., Lee, C., Rojalin, T., Carney, R.P., Hazari, S., Knudson, A., Lam, K., Saari, H., Ibanez, E.L., Viitala, T., Laaksonen, T., Yliperttula, M., Wachsmann-Hogiu, S., Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content. J. Extracell Vesicles, 4, 2015, 28533.
63. [63] Thery, C., Amigorena, S., Raposo, G., Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol., 2006 Chapter 3. (Unit 3 22).
64. [64] Van Deun, J., Mestdagh, P., Sormunen, R., Cocquyt, V., Vermaelen, K., Vandesompele, J., Bracke, M., De Wever, O., Hendrix, A., The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell Vesicles, 3, 2014.
65. [65] Zonneveld, M.I., Brisson, A.R., van Herwijnen, M.J.C., Tan, S., van de Lest, C.H.A., Redegeld, F.A., Garssen, J., Wauben, M.H.M., Nolte-t Hoen, E.N.M, Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures. J. Extracell Vesicles, 3, 2014, 24215.
66. [66] Lamparski, H.G., Metha-Damani, A., Yao, J.Y., Patel, S., Hsu, D.H., Ruegg, C., Le Pecq, J.B., Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 270 (2002), 211–226.
67. [67] Momen-Heravi, F., Balaj, L., Alian, S., Trachtenberg, A.J., Hochberg, F.H., Skog, J., Kuo, W.P., Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front. Physiol., 3, 2012, 162.
68. [68] Lane, R.E., Korbie, D., Anderson, W., Vaidyanathan, R., Trau, M., Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing. Sci. Rep., 5, 2015, 7639.
69. [69] Baranyai, T., Herczeg, K., Onodi, Z., Voszka, I., Modos, K., Marton, N., Nagy, G., Mager, I., Wood, M.J., El Andaloussi, S., Palinkas, Z., Kumar, V., Nagy, P., Kittel, A., Buzas, E.I., Ferdinandy, P., Giricz, Z., Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One, 10, 2015, e0145686.
70. [70] Nordin, J.Z., Lee, Y., Vader, P., Mager, I., Johansson, H.J., Heusermann, W., Wiklander, O.P., Hallbrink, M., Seow, Y., Bultema, J.J., Gilthorpe, J., Davies, T., Fairchild, P.J., Gabrielsson, S., Meisner-Kober, N.C., Lehtio, J., Smith, C.I., Wood, M.J., El Andaloussi, S., Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine 11 (2015), 879–883.
71. [71] Linares, R., Tan, S., Gounou, C., Arraud, N., Brisson, A.R., High-speed centrifugation induces aggregation of extracellular vesicles. J. Extracell Vesicles, 4, 2015, 29509.
72. [72] Maiolo, D., Paolini, L., Di Noto, G., Zendrini, A., Berti, D., Bergese, P., Ricotta, D., Colorimetric nanoplasmonic assay to determine purity and titrate extracellular vesicles. Anal. Chem. 87 (2015), 4168–4176.
73. [73] Cantin, R., Diou, J., Belanger, D., Tremblay, A.M., Gilbert, C., Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 338 (2008), 21–30.
74. [74] Welton, J.L., Webber, J.P., Botos, L.-A., Jones, M., Clayton, A., Ready-made chromatography columns for extracellular vesicle isolation from plasma. J. Extracell Vesicles, 4, 2015, 27269.
75. [75] Kimpton, C.P., Corbitt, G., Morris, D.J., Comparison of polyethylene glycol precipitation and ultracentrifugation for recovery of cytomegalovirus from urine prior to detection of DNA by dot-blot hybridisation. J. Virol. Methods 28 (1990), 141–145.
76. [76] Lee, C., Carney, R.P., Hazari, S., Smith, Z.J., Knudson, A., Robertson, C.S., Lam, K.S., Wachsmann-Hogiu, S., 3D plasmonic nanobowl platform for the study of exosomes in solution. Nanoscale 7 (2015), 9290–9297.
77. [77] Yoo, C.E., Kim, G., Kim, M., Park, D., Kang, H.J., Lee, M., Huh, N., A direct extraction method for microRNAs from exosomes captured by immunoaffinity beads. Anal. Biochem. 431 (2012), 96–98.
78. [78] Kim, G., Yoo, C.E., Kim, M., Kang, H.J., Park, D., Lee, M., Huh, N., Noble polymeric surface conjugated with zwitterionic moieties and antibodies for the isolation of exosomes from human serum. Bioconjug. Chem. 23 (2012), 2114–2120.
79. [79] van Dommelen, S.M., Vader, P., Lakhal, S., Kooijmans, S.A., van Solinge, W.W., Wood, M.J., Schiffelers, R.M., Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 161 (2012), 635–644.
80. [80] Balaj, L., Atai, N.A., Chen, W., Mu, D., Tannous, B.A., Breakefield, X.O., Skog, J., Maguire, C.A., Heparin affinity purification of extracellular vesicles. Sci. Rep., 5, 2015, 10266.
81. [81] Im, H., Shao, H., Park, Y.I., Peterson, V.M., Castro, C.M., Weissleder, R., Lee, H., Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat. Biotechnol. 32 (2014), 490–495.
82. [82] Grasso, L., Wyss, R., Weidenauer, L., Thampi, A., Demurtas, D., Prudent, M., Lion, N., Vogel, H., Molecular screening of cancer-derived exosomes by surface plasmon resonance spectroscopy. Anal. Bioanal. Chem. 407 (2015), 5425–5432.
83. [83] Boing, A.N., van der Pol, E., Grootemaat, A.E., Coumans, F.A., Sturk, A., Nieuwland, R., Single-step isolation of extracellular vesicles by size-exclusion chromatography. J. Extracell Vesicles, 3, 2014, 23430.
84. [84] Lobb, R.J., Becker, M., Wen, S.W., Wong, C.S., Wiegmans, A.P., Leimgruber, A., Moller, A., Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell Vesicles, 4, 2015, 27031.
85. [85] Hong, C.S., Funk, S., Muller, L., Boyiadzis, M., Whiteside, T.L., Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J. Extracell Vesicles, 5, 2016, 29289.
86. [86] Muller, L., Hong, C.-S., Stolz, D.B., Watkins, S.C., Whiteside, T.L., Isolation of biologically-active exosomes from human plasma. J. Immunol. Methods 411 (2014), 55–65.
87. [87] Yanez-Mo, M., Siljander, P.R., Andreu, Z., Zavec, A.B., Borras, F.E., Buzas, E.I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., Colas, E., Silva, A.C.-d., Fais, S., Falcon-Perez, J.M., Ghobrial, I.M., Giebel, B., Gimona, M., Graner, M., Gursel, I., Gursel, M., Heegaard, N.H., Hendrix, A., Kierulf, P., Kokubun, K., Kosanovic, M., Kralj-Iglic, V., Kramer-Albers, E.M., Laitinen, S., Lasser, C., Lener, T., Ligeti, E., Line, A., Lipps, G., Llorente, A., Lotvall, J., Mancek-Keber, M., Marcilla, A., Mittelbrunn, M., Nazarenko, I., Hoen, E.N. Nolte‐'t, Nyman, T.A., O'Driscoll, L., Olivan, M., Oliveira, C., Pallinger, E., Del Portillo, H.A., Reventos, J., Rigau, M., Rohde, E., Sammar, M., Sanchez-Madrid, F., Santarem, N., Schallmoser, K., Ostenfeld, M.S., Stoorvogel, W., Stukelj, R., Van der Grein, S.G., Vasconcelos, M.H., Wauben, M.H., De Wever, O., Biological properties of extracellular vesicles and their physiological functions. J. Extracell Vesicles, 4, 2015, 27066.
88. [88] Abusamra, A.J., Zhong, Z., Zheng, X., Li, M., Ichim, T.E., Chin, J.L., Min, W.P., Tumor exosomes expressing Fas ligand mediate CD8 + T-cell apoptosis. Blood Cells Mol. Dis. 35 (2005), 169–173.
89. [89] Muller, L., Mitsuhashi, M., Simms, P., Gooding, W.E., Whiteside, T.L., Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci. Rep., 6, 2016, 20254.
90. [90] Yelamanchili, S.V., Lamberty, B.G., Rennard, D.A., Morsey, B.M., Hochfelder, C.G., Meays, B.M., Levy, E., Fox, H.S., MiR-21 in extracellular vesicles leads to neurotoxicity via TLR7 signaling in SIV neurological disease. PLoS Pathog., 11, 2015, e1005032.
91. [91] Montecalvo, A., Larregina, A.T., Shufesky, W.J., Stolz, D.B., Sullivan, M.L., Karlsson, J.M., Baty, C.J., Gibson, G.A., Erdos, G., Wang, Z., Milosevic, J., Tkacheva, O.A., Divito, S.J., Jordan, R., Lyons-Weiler, J., Watkins, S.C., Morelli, A.E., Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119 (2012), 756–766.
92. [92] Viaud, S., Thery, C., Ploix, S., Tursz, T., Lapierre, V., Lantz, O., Zitvogel, L., Chaput, N., Dendritic cell-derived exosomes for cancer immunotherapy: what's next?. Cancer Res. 70 (2010), 1281–1285.
93. [93] Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., Morando, L., Busca, A., Falda, M., Bussolati, B., Tetta, C., Camussi, G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20 (2009), 1053–1067.
94. [94] Zhang, H.C., Liu, X.B., Huang, S., Bi, X.Y., Wang, H.X., Xie, L.X., Wang, Y.Q., Cao, X.F., Lv, J., Xiao, F.J., Yang, Y., Guo, Z.K., Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 21 (2012), 3289–3297.
95. [95] Arslan, F., Lai, R.C., Smeets, M.B., Akeroyd, L., Choo, A., Aguor, E.N., Timmers, L., van Rijen, H.V., Doevendans, P.A., Pasterkamp, G., Lim, S.K., de Kleijn, D.P., Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 10 (2013), 301–312.
96. [96] Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., Wang, M., Zhou, Y., Zhu, W., Li, W., Xu, W., Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22 (2013), 845–854.
97. [97] Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Zhang, Z.G., Chopp, M., Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30 (2012), 1556–1564.
98. [98] Favaro, E., Carpanetto, A., Lamorte, S., Fusco, A., Caorsi, C., Deregibus, M.C., Bruno, S., Amoroso, A., Giovarelli, M., Porta, M., Perin, P.C., Tetta, C., Camussi, G., Zanone, M.M., Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes. Diabetologia 57 (2014), 1664–1673.
99. [99] Kordelas, L., Rebmann, V., Ludwig, A.K., Radtke, S., Ruesing, J., Doeppner, T.R., Epple, M., Horn, P.A., Beelen, D.W., Giebel, B., MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28 (2014), 970–973.
100. [100] Phinney, D.G., Di Giuseppe, M., Njah, J., Sala, E., Shiva, S., Croix, C.M.S., Stolz, D.B., Watkins, S.C., Di, Y.P., Leikauf, G.D., Kolls, J., Riches, D.W.H., Deiuliis, G., Kaminski, N., Boregowda, S.V., McKenna, D.H., Ortiz, L.A., Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat. Commun., 6, 2015, 8472.
101. [101] Ferguson, S., Nguyen, J., Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity. J. Control. Release 228 (2016), 179–190.
102. [102] Rani, S., Ryan, A.E., Griffin, M.D., Ritter, T., Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol. Ther. 23 (2015), 812–823.
103. [103] Akyurekli, C., Le, Y., Richardson, R.B., Fergusson, D., Tay, J., Allan, D.S., A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev. 11 (2015), 150–160.
104. [104] Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y., Takagaki, K., Oki, K., Takeshita, F., Sakai, Y., Kuroda, M., Ochiya, T., Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci. Rep., 3, 2013, 1197.
105. [105] Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M., De Medina, P., Monsarrat, B., Perret, B., Silvente-Poirot, S., Poirot, M., Record, M., Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 51 (2010), 2105–2120.
106. [106] Waldenstrom, A., Genneback, N., Hellman, U., Ronquist, G., Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One, 7, 2012, e34653.
107. [107] Raemdonck, K., De Smedt, S.C., Lessons in simplicity that should shape the future of drug delivery. Nat. Biotechnol. 33 (2015), 1026–1027.
108. [108] Nayerossadat, N., Maedeh, T., Ali, P.A., Viral and nonviral delivery systems for gene delivery. Adv. Biomed. Res., 1, 2012, 27.
109. [109] van den Boorn, J.G., Schlee, M., Coch, C., Hartmann, G., SiRNA delivery with exosome nanoparticles. Nat. Biotechnol. 29 (2011), 325–326.
110. [110] Allen, T.M., Austin, G.A., Chonn, A., Lin, L., Lee, K.C., Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim. Biophys. Acta 1061 (1991), 56–64.
111. [111] Teissier, E., Pecheur, E.I., Lipids as modulators of membrane fusion mediated by viral fusion proteins. Eur. Biophys. J. 36 (2007), 887–899.
112. [112] Jegou, A., Ziyyat, A., Barraud-Lange, V., Perez, E., Wolf, J.P., Pincet, F., Gourier, C., CD9 tetraspanin generates fusion competent sites on the egg membrane for mammalian fertilization. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10946–10951.
113. [113] Martin, F., Roth, D.M., Jans, D.A., Pouton, C.W., Partridge, L.J., Monk, P.N., Moseley, G.W., Tetraspanins in viral infections: a fundamental role in viral biology?. J. Virol. 79 (2005), 10839–10851.
114. [114] Hoshino, A., Costa-Silva, B., Shen, T.L., Rodrigues, G., Hashimoto, A., Mark, M.T., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., Singh, S., Williams, C., Soplop, N., Uryu, K., Pharmer, L., King, T., Bojmar, L., Davies, A.E., Ararso, Y., Zhang, T., Zhang, H., Hernandez, J., Weiss, J.M., Dumont-Cole, V.D., Kramer, K., Wexler, L.H., Narendran, A., Schwartz, G.K., Healey, J.H., Sandstrom, P., Labori, K.J., Kure, E.H., Grandgenett, P.M., Hollingsworth, M.A., de Sousa, M., Kaur, S., Jain, M., Mallya, K., Batra, S.K., Jarnagin, W.R., Brady, M.S., Fodstad, O., Muller, V., Pantel, K., Minn, A.J., Bissell, M.J., Garcia, B.A., Kang, Y., Rajasekhar, V.K., Ghajar, C.M., Matei, I., Peinado, H., Bromberg, J., Lyden, D., Tumour exosome integrins determine organotropic metastasis. Nature, 2015.
115. [115] Takahashi, Y., Nishikawa, M., Shinotsuka, H., Matsui, Y., Ohara, S., Imai, T., Takakura, Y., Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J. Biotechnol. 165 (2013), 77–84.
116. [116] Saunderson, S.C., Dunn, A.C., Crocker, P.R., McLellan, A.D., CD169 mediates the capture of exosomes in spleen and lymph node. Blood 123 (2014), 208–216.
117. [117] Lai, C.P., Mardini, O., Ericsson, M., Prabhakar, S., Maguire, C.A., Chen, J.W., Tannous, B.A., Breakefield, X.O., Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 8 (2014), 483–494.
118. [118] Smyth, T., Kullberg, M., Malik, N., Smith-Jones, P., Graner, M.W., Anchordoquy, T.J., Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J. Control. Release 199C (2014), 145–155.
119. [119] Wiklander, O.P., Nordin, J.Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mager, I., Vader, P., Lee, Y., Sork, H., Seow, Y., Heldring, N., Alvarez-Erviti, L., Smith, C.E., Le Blanc, K., Macchiarini, P., Jungebluth, P., Wood, M.J., Andaloussi, S.E., Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell Vesicles, 4, 2015, 26316.
120. [120] Deschout, H., Raemdonck, K., Stremersch, S., Maoddi, P., Mernier, G., Renaud, P., Jiguet, S., Hendrix, A., Bracke, M., Van den Broecke, R., Roding, M., Rudemo, M., Demeester, J., De Smedt, S.C., Strubbe, F., Neyts, K., Braeckmans, K., On-chip light sheet illumination enables diagnostic size and concentration measurements of membrane vesicles in biofluids. Nanoscale 6 (2014), 1741–1747.
121. [121] Fomina, A.F., Deerinck, T.J., Ellisman, M.H., Cahalan, M.D., Regulation of membrane trafficking and subcellular organization of endocytic compartments revealed with FM1-43 in resting and activated human T cells. Exp. Cell Res. 291 (2003), 150–166.
122. [122] Clayton, A., Harris, C.L., Court, J., Mason, M.D., Morgan, B.P., Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33 (2003), 522–531.
123. [123] Whitehead, B., Wu, L., Hvam, M.L., Aslan, H., Dong, M., Dyrskjot, L., Ostenfeld, M.S., Moghimi, S.M., Howard, K.A., Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness. J. Extracell Vesicles, 4, 2015, 29685.
124. [124] Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (2011), 341–345.
125. [125] Tao, Y., Han, J., Dou, H., Brain-targeting gene delivery using a rabies virus glycoprotein peptide modulated hollow liposome: bio-behavioral study. J. Math. Chem. 22 (2012), 11808–11815.
126. [126] Hung, M.E., Leonard, J.N., Stabilization of exosome-targeting peptides via engineered glycosylation. J. Biol. Chem. 290 (2015), 8166–8172.
127. [127] Kooijmans, S.A., Fliervoet, L.A., van der Meel, R., Fens, M.H., Heijnen, H.F., van Bergen En Henegouwen, P.M., Vader, P., Schiffelers, R.M., PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J. Control. Release 224 (2016), 77–85.
128. [128] Sato, Y.T., Umezaki, K., Sawada, S., Mukai, S.A., Sasaki, Y., Harada, N., Shiku, H., Akiyoshi, K., Engineering hybrid exosomes by membrane fusion with liposomes. Sci. Rep., 6, 2016, 21933.
129. [129] Ridder, K., Keller, S., Dams, M., Rupp, A.K., Schlaudraff, J., Del Turco, D., Starmann, J., Macas, J., Karpova, D., Devraj, K., Depboylu, C., Landfried, B., Arnold, B., Plate, K.H., Hoglinger, G., Sultmann, H., Altevogt, P., Momma, S., Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol., 12, 2014, e1001874.
130. [130] Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol. 19 (2009), 43–51.
131. [131] Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V.P., Lockman, P., Bai, S., Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm. Res. 32 (2015), 2003–2014.
132. [132] Ohno, S.I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., Gotoh, N., Kuroda, M., Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther., 2012.
133. [133] Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G.J., Wei, J., Nie, G., A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35 (2014), 2383–2390.
134. [134] Ruiss, R., Jochum, S., Mocikat, R., Hammerschmidt, W., Zeidler, R., EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells-a new option for the treatment of B-CLL. PLoS One, 6, 2011.
135. [135] Hood, J.L., San, R.S., Wickline, S.A., Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71 (2011), 3792–3801.
136. [136] Hu, L., Wickline, S.A., Hood, J.L., Magnetic resonance imaging of melanoma exosomes in lymph nodes. Magn. Reson. Med. 74 (2015), 266–271.
137. [137] Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R.C., Ju, S., Mu, J., Zhang, L., Steinman, L., Miller, D., Zhang, H.G., Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19 (2011), 1769–1779.
138. [138] Haney, M.J., Klyachko, N.L., Zhao, Y., Gupta, R., Plotnikova, E.G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A.V., Batrakova, E.V., Exosomes as drug delivery vehicles for Parkinson's disease therapy. J. Control. Release 207 (2015), 18–30.
139. [139] Mulcahy, L.A., Pink, R.C., Carter, D.R., Routes and mechanisms of extracellular vesicle uptake. J. Extracell Vesicles, 3, 2014, 24641.
140. [140] Heusermann, W., Hean, J., Trojer, D., Steib, E., von Bueren, S., Graff-Meyer, A., Genoud, C., Martin, K., Pizzato, N., Voshol, J., Morrissey, D.V., Andaloussi, S.E., Wood, M.J., Meisner-Kober, N.C., Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J. Cell Biol. 213 (2016), 173–184.
141. [141] Martens, T.F., Remaut, K., Demeester, J., De Smedt, S.C., Braeckmans, K., Intracellular delivery of nanomaterials: how to catch endosomal escape in the act. Nano Today 9 (2014), 344–364.
142. [142] Temchura, V.V., Tenbusch, M., Nchinda, G., Nabi, G., Tippler, B., Zelenyuk, M., Wildner, O., Uberla, K., Kuate, S., Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus. Vaccine 26 (2008), 3662–3672.
143. [143] Matlin, K.S., Reggio, H., Helenius, A., Simons, K., Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156 (1982), 609–631.
144. [144] Alvarez-Erviti, L., Seow, Y.Q., Yin, H.F., Betts, C., Lakhal, S., Wood, M.J.A., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol., 29, 2011 (341-U179).
145. [145] Zou, L.L., Ma, J.L., Wang, T., Yang, T.B., Liu, C.B., Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system. Curr. Neuropharmacol. 11 (2013), 197–208.
146. [146] Teesalu, T., Sugahara, K.N., Ruoslahti, E., Tumor-Penetrating Peptides. Front. Oncol., 3, 2013, 216.
147. [147] Atay, S., Gercel-Taylor, C., Taylor, D.D., Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1beta production by macrophages. Am. J. Reprod. Immunol. 66 (2011), 259–269.
148. [148] Cossetti, C., Iraci, N., Mercer, T.R., Leonardi, T., Alpi, E., Drago, D., Alfaro-Cervello, C., Saini, H.K., Davis, M.P., Schaeffer, J., Vega, B., Stefanini, M., Zhao, C., Muller, W., Garcia-Verdugo, J.M., Mathivanan, S., Bachi, A., Enright, A.J., Mattick, J.S., Pluchino, S., Extracellular vesicles from neural stem cells transfer IFN-gamma via Ifngr1 to activate Stat1 signaling in target cells. Mol. Cell 56 (2014), 193–204.
149. [149] Hedlund, M., Nagaeva, O., Kargl, D., Baranov, V., Mincheva-Nilsson, L., Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One, 6, 2011, e16899.
150. [150] Clayton, A., Al-Taei, S., Webber, J., Mason, M.D., Tabi, Z., Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. 187 (2011), 676–683.
151. [151] Vader, P., Kooijmans, S.A., Stremersch, S., Raemdonck, K., New considerations in the preparation of nucleic acid-loaded extracellular vesicles. Ther. Deliv. 5 (2014), 105–107.
152. [152] Pascucci, L., Cocce, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Vigano, L., Locatelli, A., Sisto, F., Doglia, S.M., Parati, E., Bernardo, M.E., Muraca, M., Alessandri, G., Bondiolotti, G., Pessina, A., Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J. Control. Release, 2014, 262–270.
153. [153] Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., Ochiya, T., Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285 (2010), 17442–17452.
154. [154] Liu, Y., Li, D., Liu, Z., Zhou, Y., Chu, D., Li, X., Jiang, X., Hou, D., Chen, X., Chen, Y., Yang, Z., Jin, L., Jiang, W., Tian, C., Zhou, G., Zen, K., Zhang, J., Zhang, Y., Li, J., Zhang, C.Y., Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse. Sci. Rep., 5, 2015, 17543.
155. [155] Zomer, A., Maynard, C., Verweij, F.J., Kamermans, A., Schafer, R., Beerling, E., Schiffelers, R.M., de Wit, E., Berenguer, J., Ellenbroek, S.I., Wurdinger, T., Pegtel, D.M., van Rheenen, J., In Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161 (2015), 1046–1057.
156. [156] Shen, B., Wu, N., Yang, J.M., Gould, S.J., Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 286 (2011), 14383–14395.
157. [157] Hartman, Z.C., Wei, J., Glass, O.K., Guo, H., Lei, G., Yang, X.Y., Osada, T., Hobeika, A., Delcayre, A., Le Pecq, J.B., Morse, M.A., Clay, T.M., Lyerly, H.K., Increasing vaccine potency through exosome antigen targeting. Vaccine 29 (2011), 9361–9367.
158. [158] Stickney, Z., Losacco, J., McDevitt, S., Zhang, Z., Lu, B., Development of exosome surface display technology in living human cells. Biochem. Biophys. Res. Commun. 472 (2016), 53–59.
159. [159] Cha, D.J., Franklin, J.L., Dou, Y., Liu, Q., Higginbotham, J.N., Demory Beckler, M., Weaver, A.M., Vickers, K., Prasad, N., Levy, S., Zhang, B., Coffey, R.J., Patton, J.G., KRAS-dependent sorting of miRNA to exosomes. eLife, 4, 2015, e07197.
160. [160] Maguire, C.A., Balaj, L., Sivaraman, S., Crommentuijn, M.H., Ericsson, M., Mincheva-Nilsson, L., Baranov, V., Gianni, D., Tannous, B.A., Sena-Esteves, M., Breakefield, X.O., Skog, J., Microvesicle-associated AAV vector as a novel gene delivery system. Mol. Ther. 20 (2012), 960–971.
161. [161] Gyorgy, B., Fitzpatrick, Z., Crommentuijn, M.H., Mu, D., Maguire, C.A., Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo. Biomaterials 35 (2014), 7598–7609.
162. [162] Hudry, E., Martin, C., Gandhi, S., Gyorgy, B., Scheffer, D.I., Mu, D., Merkel, S.F., Mingozzi, F., Fitzpatrick, Z., Dimant, H., Masek, M., Ragan, T., Tan, S., Brisson, A.R., Ramirez, S.H., Hyman, B.T., Maguire, C.A., Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Ther. 23 (2016), 380–392.
163. [163] Potter, H., Transfection by electroporation. Curr. Protoc. Mol. Biol., 2003 Chapter 9. (Unit 9 3).
164. [164] Cooper, J.M., Wiklander, P.B., Nordin, J.Z., Al-Shawi, R., Wood, M.J., Vithlani, M., Schapira, A.H., Simons, J.P., El-Andaloussi, S., Alvarez-Erviti, L., Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord. 29 (2014), 1476–1485.
165. [165] Chen, G., Zhu, J.Y., Zhang, Z.L., Zhang, W., Ren, J.G., Wu, M., Hong, Z.Y., Lv, C., Pang, D.W., Zhao, Y.F., Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery. Angew. Chem. Int. Ed. Eng. 54 (2014), 1036–1040.
166. [166] Lamichhane, T.N., Raiker, R.S., Jay, S.M., Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol. Pharm. 12 (2015), 3650–3657.
167. [167] Shtam, T.A., Kovalev, R.A., Varfolomeeva, E.Y., Makarov, E.M., Kil, Y.V., Filatov, M.V., Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell commun signal, 11, 2013, 88.
168. [168] Wahlgren, J., De, L.K.T., Brisslert, M., Vaziri Sani, F., Telemo, E., Sunnerhagen, P., Valadi, H., Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res., 40, 2012, e130.
169. [169] Kooijmans, S.A., Stremersch, S., Braeckmans, K., de Smedt, S.C., Hendrix, A., Wood, M.J., Schiffelers, R.M., Raemdonck, K., Vader, P., Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J. Control. Release 172 (2013), 229–238.
170. [170] Hood, J.L., Scott, M.J., Wickline, S.A., Maximizing exosome colloidal stability following electroporation. Anal. Biochem. 448 (2014), 41–49.
171. [171] Johnsen, K.B., Gudbergsson, J.M., Skov, M.N., Christiansen, G., Gurevich, L., Moos, T., Duroux, M., Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology, 2016, 1–14.
172. [172] Fuhrmann, G., Serio, A., Mazo, M., Nair, R., Stevens, M.M., Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J. Control. Release 205 (2015), 35–44.
173. [173] Bryniarski, K., Ptak, W., Martin, E., Nazimek, K., Szczepanik, M., Sanak, M., Askenase, P.W., Free extracellular miRNA functionally targets cells by transfecting exosomes from their companion cells. PLoS One, 10, 2015, e0122991.
174. [174] Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H.G., A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18 (2010), 1606–1614.
175. [175] Saari, H., Lazaro-Ibanez, E., Viitala, T., Vuorimaa-Laukkanen, E., Siljander, P., Yliperttula, M., Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J. Control. Release 220 (2015), 727–737.
176. [176] Stremersch, S., Vandenbroucke, R.E., Van Wonterghem, E., Hendrix, A., De Smedt, S.C., Raemdonck, K., Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs. J. Control. Release 232 (2016), 51–61.
177. [177] Chevillet, J.R., Kang, Q., Ruf, I.K., Briggs, H.A., Vojtech, L.N., Hughes, S.M., Cheng, H.H., Arroyo, J.D., Meredith, E.K., Gallichotte, E.N., Pogosova-Agadjanyan, E.L., Morrissey, C., Stirewalt, D.L., Hladik, F., Yu, E.Y., Higano, C.S., Tewari, M., Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 14888–14893.
178. [178] Hung, M.E., Leonard, J.N., A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. J. Extracell Vesicles, 5, 2016, 31027.
179. [179] Yeo, R.W., Lai, R.C., Zhang, B., Tan, S.S., Yin, Y., Teh, B.J., Lim, S.K., Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Adv. Drug Deliv. Rev. 65 (2012), 336–341.
180. [180] Zhu, W., Huang, L., Li, Y., Zhang, X., Gu, J., Yan, Y., Xu, X., Wang, M., Qian, H., Xu, W., Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 315 (2012), 28–37.
181. [181] Yin, W., Ouyang, S., Li, Y., Xiao, B., Yang, H., Immature dendritic cell-derived exosomes: a promise subcellular vaccine for autoimmunity. Inflammation 36 (2013), 232–240.
182. [182] Wang, Q., Ren, Y., Mu, J., Egilmez, N.K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., Zhang, H.G., Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Res. 75 (2015), 2520–2529.
183. [183] Munagala, R., Aqil, F., Jeyabalan, J., Gupta, R.C., Bovine milk-derived exosomes for drug delivery. Cancer Lett. 371 (2016), 48–61.
184. [184] Wang, Q., Zhuang, X., Mu, J., Deng, Z.B., Jiang, H., Zhang, L., Xiang, X., Wang, B., Yan, J., Miller, D., Zhang, H.G., Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat. Commun., 4, 2013, 1867.
185. [185] Jo, W., Jeong, D., Kim, J., Cho, S., Jang, S.C., Han, C., Kang, J.Y., Gho, Y.S., Park, J., Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. Lab Chip 14 (2014), 1261–1269.
186. [186] Jang, S.C., Kim, O.Y., Yoon, C.M., Choi, D.S., Roh, T.Y., Park, J., Nilsson, J., Lotvall, J., Kim, Y.K., Gho, Y.S., Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7 (2013), 7698–7710.
187. [187] Kooijmans, S.A., Vader, P., van Dommelen, S.M., van Solinge, W.W., Schiffelers, R.M., Exosome mimetics: a novel class of drug delivery systems. Int. J. Nanomedicine 7 (2012), 1525–1541.
188. [188] Andre, F., Chaput, N., Schartz, N.E., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D.H., Tursz, T., Amigorena, S., Angevin, E., Zitvogel, L., Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172 (2004), 2126–2136.
189. [189] Thery, C., Duban, L., Segura, E., Veron, P., Lantz, O., Amigorena, S., Indirect activation of naive CD4 + T cells by dendritic cell-derived exosomes. Nat. Immunol. 3 (2002), 1156–1162.
190. [190] Morse, M.A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T.M., Valente, N., Shreeniwas, R., Sutton, M.A., Delcayre, A., Hsu, D.H., Le Pecq, J.B., Lyerly, H.K., A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med., 3, 2005, 9.
191. [191] Chaput, N., Schartz, N.E., Andre, F., Taieb, J., Novault, S., Bonnaventure, P., Aubert, N., Bernard, J., Lemonnier, F., Merad, M., Adema, G., Adams, M., Ferrantini, M., Carpentier, A.F., Escudier, B., Tursz, T., Angevin, E., Zitvogel, L., Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172 (2004), 2137–2146.
192. [192] Guo, F., Chang, C.K., Fan, H.H., Nie, X.X., Ren, Y.N., Liu, Y.Y., Zhao, L.H., Anti-tumour effects of exosomes in combination with cyclophosphamide and polyinosinic-polycytidylic acid. J. Int. Med. Res. 36 (2008), 1342–1353.
193. [193] Gehrmann, U., Hiltbrunner, S., Georgoudaki, A.M., Karlsson, M.C., Naslund, T.I., Gabrielsson, S., Synergistic induction of adaptive antitumor immunity by codelivery of antigen with alpha-galactosylceramide on exosomes. Cancer Res. 73 (2013), 3865–3876.
194. [194] Viaud, S., Ploix, S., Lapierre, V., Thery, C., Commere, P.H., Tramalloni, D., Gorrichon, K., Virault-Rocroy, P., Tursz, T., Lantz, O., Zitvogel, L., Chaput, N., Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-gamma. J. Immunother. 34 (2011), 65–75.
195. [195] Liu, T., Mendes, D.E., Berkman, C.E., Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells. Int. J. Oncol. 44 (2014), 918–922.
196. [196] Zeelenberg, I.S., van Maren, W.W., Boissonnas, A., Van Hout-Kuijer, M.A., Den Brok, M.H., Wagenaars, J.A., van der Schaaf, A., Jansen, E.J., Amigorena, S., Thery, C., Figdor, C.G., Adema, G.J., Antigen localization controls T cell-mediated tumor immunity. J. Immunol. 187 (2011), 1281–1288.
197. [197] Gu, X., Erb, U., Buchler, M.W., Zoller, M., Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice. Int. J. Cancer 136 (2014), 74–84.
198. [198] Mahaweni, N., Lambers, M., Dekkers, J., Aerts, J., Hegmans, J., Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma. J. Extracell Vesicless, 2, 2013, 22492.
199. [199] Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., Li, G., Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16 (2008), 782–790.
200. [200] Yang, C., Robbins, P.D., The roles of tumor-derived exosomes in cancer pathogenesis. Clin. Dev. Immunol., 2011, 2011, 842849.
201. [201] Cho, J.A., Lee, Y.S., Kim, S.H., Ko, J.K., Kim, C.W., MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett. 275 (2009), 256–265.
202. [202] Dai, S., Zhou, X., Wang, B., Wang, Q., Fu, Y., Chen, T., Wan, T., Yu, Y., Cao, X., Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. J. Mol. Med. (Berl.) 84 (2006), 1067–1076.
203. [203] Zhang, Y., Luo, C.L., He, B.C., Zhang, J.M., Cheng, G., Wu, X.H., Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int. J. Oncol. 36 (2010), 133–140.
204. [204] Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., Stringaro, A., Molinari, A., Arancia, G., Gentile, M., Parmiani, G., Fais, S., Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195 (2002), 1303–1316.
205. [205] Clayton, A., Mitchell, J.P., Court, J., Mason, M.D., Tabi, Z., Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 67 (2007), 7458–7466.
206. [206] Clayton, A., Mitchell, J.P., Court, J., Linnane, S., Mason, M.D., Tabi, Z., Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 180 (2008), 7249–7258.
207. [207] Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., Garcia-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K., Garcia, B.A., Callahan, M.K., Yuan, J., Martins, V.R., Skog, J., Kaplan, R.N., Brady, M.S., Wolchok, J.D., Chapman, P.B., Kang, Y., Bromberg, J., Lyden, D., Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18 (2012), 883–891.
208. [208] Ginestra, A., La Placa, M.D., Saladino, F., Cassara, D., Nagase, H., Vittorelli, M.L., The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 18 (1998), 3433–3437.
209. [209] Lee, E.Y., Park, K.S., Yoon, Y.J., Lee, J., Moon, H.G., Jang, S.C., Choi, K.H., Kim, Y.K., Gho, Y.S., Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis. PLoS One, 7, 2012, e33330.
210. [210] Sedlik, C., Vigneron, J., Torrieri-Dramard, L., Pitoiset, F., Denizeau, J., Chesneau, C., de la Rochere, P., Lantz, O., Thery, C., Bellier, B., Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms. J. Extracell Vesicles, 3, 2014, 24646.
211. [211] Robbins, P.D., Morelli, A.E., Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14 (2014), 195–208.
212. [212] van der Pol, L., Stork, M., van der Ley, P., Outer membrane vesicles as platform vaccine technology. Biotechnol. J. 10 (2015), 1689–1706.
213. [213] Strimbu, K., Tavel, J.A., What are biomarkers?. Curr. Opin. HIV AIDS 5 (2010), 463–466.
214. [214] Brawer, M.K., Cheli, C.D., Neaman, I.E., Goldblatt, J., Smith, C., Schwartz, M.K., Bruzek, D.J., Morris, D.L., Sokoll, L.J., Chan, D.W., Yeung, K.K., Partin, A.W., Allard, W.J., Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J. Urol. 163 (2000), 1476–1480.
215. [215] Burrell, R.A., McGranahan, N., Bartek, J., Swanton, C., The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501 (2013), 338–345.
216. [216] Olsen, D., Jorgensen, J.T., Companion diagnostics for targeted cancer drugs - clinical and regulatory aspects. Front. Oncol., 4, 2014, 105.
217. [217] Rabinowits, G., Gercel-Taylor, C., Day, J.M., Taylor, D.D., Kloecker, G.H., Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10 (2009), 42–46.
218. [218] Garnier, D., Jabado, N., Rak, J., Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours. Proteomics 13 (2013), 1595–1607.
219. [219] de Jong, O.G., Verhaar, M.C., Chen, Y., Vader, P., Gremmels, H., Posthuma, G., Schiffelers, R.M., Gucek, M., van Balkom, B.W., Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles, 1, 2012, 18396.
220. [220] Suetsugu, A., Honma, K., Saji, S., Moriwaki, H., Ochiya, T., Hoffman, R.M., Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv. Drug Deliv. Rev. 65 (2013), 383–390.
221. [221] Lasser, C., Alikhani, V.S., Ekstrom, K., Eldh, M., Paredes, P.T., Bossios, A., Sjostrand, M., Gabrielsson, S., Lotvall, J., Valadi, H., Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J. Transl. Med., 9, 2011, 9.
222. [222] Dismuke, W.M., Challa, P., Navarro, I., Stamer, W.D., Liu, Y., Human aqueous humor exosomes. Exp. Eye Res. 132 (2015), 73–77.
223. [223] Street, J.M., Barran, P.E., Mackay, C.L., Weidt, S., Balmforth, C., Walsh, T.S., Chalmers, R.T., Webb, D.J., Dear, J.W., Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J. Transl. Med., 10, 2012, 5.
224. [224] Tokuhisa, M., Ichikawa, Y., Kosaka, N., Ochiya, T., Yashiro, M., Hirakawa, K., Kosaka, T., Makino, H., Akiyama, H., Kunisaki, C., Endo, I., Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS One, 10, 2015, e0130472.
225. [225] Admyre, C., Grunewald, J., Thyberg, J., Gripenback, S., Tornling, G., Eklund, A., Scheynius, A., Gabrielsson, S., Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J. 22 (2003), 578–583.
226. [226] Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., Rak, J., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10 (2008), 619–624.
227. [227] Wieckowski, E.U., Visus, C., Szajnik, M., Szczepanski, M.J., Storkus, W.J., Whiteside, T.L., Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8 + T lymphocytes. J. Immunol. 183 (2009), 3720–3730.
228. [228] Wurdinger, T., Gatson, N.N., Balaj, L., Kaur, B., Breakefield, X.O., Pegtel, D.M., Extracellular vesicles and their convergence with viral pathways. Adv. Virol., 2012, 2012, 767694.
229. [229] Colombo, E., Borgiani, B., Verderio, C., Furlan, R., Microvesicles: novel biomarkers for neurological disorders. Front. Physiol., 3, 2012, 63.
230. [230] Muller, G., Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab. Syndr. Obes. 5 (2012), 247–282.
231. [231] Danielson, K.M., Das, S., extracellular vesicles in heart disease: excitement for the future?. Exosomes microvesicles, 2, 2014.
232. [232] Tavoosidana, G., Ronquist, G., Darmanis, S., Yan, J., Carlsson, L., Wu, D., Conze, T., Ek, P., Semjonow, A., Eltze, E., Larsson, A., Landegren, U.D., Kamali-Moghaddam, M., Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 8809–8814.
233. [233] Taylor, D.D., Gercel-Taylor, C., MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110 (2008), 13–21.
234. [234] Silva, J., Garcia, V., Rodriguez, M., Compte, M., Cisneros, E., Veguillas, P., Garcia, J.M., Dominguez, G., Campos-Martin, Y., Cuevas, J., Pena, C., Herrera, M., Diaz, R., Mohammed, N., Bonilla, F., Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosom. Cancer 51 (2012), 409–418.
235. [235] Wang, W., Li, H., Zhou, Y., Jie, S., Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma. Cancer Biomark. 13 (2013), 351–357.
236. [236] Fruhbeis, C., Helmig, S., Tug, S., Simon, P., Kramer-Albers, E.M., Physical exercise induces rapid release of small extracellular vesicles into the circulation. J. Extracell Vesicles, 4, 2015, 28239.
237. [237] Smalley, D.M., Sheman, N.E., Nelson, K., Theodorescu, D., Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J. Proteome Res. 7 (2008), 2088–2096.
238. [238] Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W.N., Pass, H.I., microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J. Thorac. Oncol. 8 (2013), 1156–1162.
239. [239] An, T., Qin, S., Xu, Y., Tang, Y., Huang, Y., Situ, B., Inal, J.M., Zheng, L., Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J. Extracell Vesicles, 4, 2015, 27522.
240. [240] van Balkom, B.W., Pisitkun, T., Verhaar, M.C., Knepper, M.A., Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int. 80 (2011), 1138–1145.
241. [241] Pant, S., Hilton, H., Burczynski, M.E., The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem. Pharmacol. 83 (2012), 1484–1494.
242. [242] Shi, M., Liu, C., Cook, T.J., Bullock, K.M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., Hipp, M.J., Zabetian, C.P., Peskind, E.R., Hu, S.C., Quinn, J.F., Galasko, D.R., Banks, W.A., Zhang, J., Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 128 (2014), 639–650.
243. [243] DeSantis, M.C., Cheng, W., Label-free Detection and Manipulation of Single Biological Nanoparticles. 2016, Wiley Interdiscip Rev Nanomed Nanobiotechnol.
244. [244] Groot Kormelink, T., Arkesteijn, G.J., Nauwelaers, F.A., van den Engh, G., Nolte-'t Hoen, E.N., Wauben, M.H., Prerequisites for the analysis and sorting of extracellular vesicle subpopulations by high-resolution flow cytometry. Cytometry A: the J. Int. Soc. Anal. Cytology 89 (2016), 135–147.
245. [245] Arakelyan, A., Ivanova, O., Vasilieva, E., Grivel, J.-C., Margolis, L., Antigenic composition of single nano-sized extracellular blood vesicles. Nanomedicine: Nanotech., Biol. Med. 11 (2015), 489–498.
246. [246] Nolte-'t Hoen, E.N.M., van der Vlist, E.J., de Boer-Brouwer, M., Arkesteijn, G.J.A., Stoorvogel, W., Wauben, M.H.M., Dynamics of dendritic cell-derived vesicles: high-resolution flow cytometric analysis of extracellular vesicle quantity and quality. J. Leukoc. Biol. 93 (2013), 395–402.
247. [247] Stremersch, S., Marro, M., Pinchasik, B.-E., Baatsen, P., Hendrix, A., De Smedt, S.C., Loza-Alvarez, P., Skirtach, A.G., Raemdonck, K., Braeckmans, K., Identification of individual exosome-like vesicles by surface enhanced raman spectroscopy. Small 12 (2016), 3292–3301.
248. [248] Sheridan, C., Exosome cancer diagnostic reaches market. Nat. Biotechnol. 34 (2016), 359–360.
249. [249] Mora, E.M., Alvarez-Cubela, S., Oltra, E., Biobanking of exosomes in the era of precision medicine: are we there yet?. Int. J. Mol. Sci., 17, 2015, 13.
250. [250] Gyorgy, B., Paloczi, K., Kovacs, A., Barabas, E., Beko, G., Varnai, K., Pallinger, E., Szabo-Taylor, K., Szabo, T.G., Kiss, A.A., Falus, A., Buzas, E.I., Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube. Thromb. Res. 133 (2014), 285–292.
251. [251] Rubin, O., Crettaz, D., Tissot, J.D., Lion, N., Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 82 (2010), 1–8.
252. [252] Witwer, K.W., Buzas, E.I., Bemis, L.T., Bora, A., Lasser, C., Lotvall, J., Nolte-'t Hoen, E.N., Piper, M.G., Sivaraman, S., Skog, J., Thery, C., Wauben, M.H., Hochberg, F., Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell Vesicles, 2, 2013, 20360.
253. [253] Besse, B., Charrier, M., Lapierre, V., Dansin, E., Lantz, O., Planchard, D., Le Chevalier, T., Livartoski, A., Barlesi, F., Laplanche, A., Ploix, S., Vimond, N., Peguillet, I., Théry, C., Lacroix, L., Zoernig, I., Dhodapkar, K., Dhodapkar, M., Viaud, S., Soria, J.-C., Reiners, K.S., von Strandmann, E.P., Vély, F., Rusakiewicz, S., Eggermont, A., Pitt, J.M., Zitvogel, L., Chaput, N., Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. OncoImmunology, 5, 2015, e1071008.
254. [254] Nakase, I., Futaki, S., Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci. Rep., 5, 2015, 10112.
255. [255] Akao, Y., Iio, A., Itoh, T., Noguchi, S., Itoh, Y., Ohtsuki, Y., Naoe, T., Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol. Ther. 19 (2011), 395–399.
256. [256] Mizrak, A., Bolukbasi, M.F., Ozdener, G.B., Brenner, G.J., Madlener, S., Erkan, E.P., Strobel, T., Breakefield, X.O., Saydam, O., Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol. Ther. 21 (2013), 101–108.
257. [257] Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.D., Song, E., Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer, 10, 2011, 117.
258. [258] Zhang, Y., Li, L., Yu, J., Zhu, D., Zhang, Y., Li, X., Gu, H., Zhang, C.Y., Zen, K., Microvesicle-mediated delivery of transforming growth factor beta1 siRNA for the suppression of tumor growth in mice. Biomaterials 35 (2014), 4390–4400.
259. [259] Silva, A.K., Luciani, N., Gazeau, F., Aubertin, K., Bonneau, S., Chauvierre, C., Letourneur, D., Wilhelm, C., Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting. Nanomedicine 11 (2015), 645–655.